Lichen International Limited
LICN
$3.12
-$0.13-4.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.64M | 39.56M | 41.48M | 41.70M | 41.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.64M | 39.56M | 41.48M | 41.70M | 41.93M |
| Cost of Revenue | 16.34M | 16.07M | 15.80M | 16.14M | 16.47M |
| Gross Profit | 21.30M | 23.49M | 25.67M | 25.57M | 25.46M |
| SG&A Expenses | 32.80M | 31.51M | 30.23M | 22.29M | 14.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.14M | 47.58M | 46.03M | 38.42M | 30.82M |
| Operating Income | -11.50M | -8.03M | -4.55M | 3.28M | 11.11M |
| Income Before Tax | -15.03M | -9.60M | -4.17M | 3.52M | 11.20M |
| Income Tax Expenses | 1.04M | 1.49M | 1.95M | 2.70M | 3.45M |
| Earnings from Continuing Operations | -16.07 | -11.09 | -6.12 | 0.81 | 7.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -193.00K | -106.00K | -19.00K | -9.50K | -- |
| Net Income | -16.26M | -11.20M | -6.14M | 804.50K | 7.75M |
| EBIT | -11.50M | -8.03M | -4.55M | 3.28M | 11.11M |
| EBITDA | -9.15M | -5.79M | -2.43M | 5.31M | 13.06M |
| EPS Basic | -67.08 | -48.28 | -29.49 | 13.85 | 57.18 |
| Normalized Basic EPS | -39.08 | -25.47 | -11.87 | 19.56 | 50.99 |
| EPS Diluted | -67.08 | -48.28 | -29.49 | 13.85 | 57.18 |
| Normalized Diluted EPS | -39.08 | -25.47 | -11.87 | 19.56 | 50.99 |
| Average Basic Shares Outstanding | 971.80K | 859.00K | 746.20K | 675.60K | 605.00K |
| Average Diluted Shares Outstanding | 971.80K | 859.00K | 746.20K | 675.60K | 605.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |